Skip to main navigation
HCW Biologics, Inc. Logo
  • Home
  • Overview
  • News & Publications
    News Releases Publications
  • Events & Presentations
  • Governance
    Documents & Charters Leadership and Board Committee Composition
  • Stock
    Stock Quote & Chart Analyst Coverage
  • Financials
    SEC Filings
  • IR Resources
    Email Alerts Contact Us

Events and Presentations

Presentations
April 19, 2022
Presentation for Third Annual International Conference on Cell and Experimental Biology 2022 2.9 MB
Past Events
Sep 20, 2021
HCW Biologics Inc.(NasdaqGM:HCWB) added to S&P TMI Index
Sep 9, 2021
Meet HCW Biologics: Fly exclusive interview with CEO Hing Wong HCWB - The Fly
May 1, 2020
A Novel IL2-based Immunotherapeutic Protein Prevents the Development of Atherosclerosis in ApoE−/− mice and LDLR−/− mice
Qiongzhen li, Xiaoyun Zhu, Catherine Spanoudis, Kristine Ravelo, Mike Dee, Bai Liu, Caitlin Prendes, Lijing You and Hing Wong
J Immunol May 1, 2020, 204 (1 Supplement) 159.19
 

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
  • © HCW Biologics, Inc. 2021 - 2023